货号:GS40799
Volociximab is a chimeric monoclonal antibody that specifically targets the α5β1 integrin (also known as fibronectin receptor). It was developed as an anti-angiogenic agent for the treatment of cancer, with clinical trials conducted in solid tumors such as metastatic melanoma and non-small cell lung cancer, aiming to inhibit the formation of new tumor blood vessels.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物